CION Ameerpet
Practical · Reviewed by CION Oncologists · NABH Accredited
What Makes a Good Endometrial Cancer Centre
Choosing where to be treated is usually made on proximity, reputation or a referral, and rarely on anything a woman can actually verify. There are six things that genuinely distinguish a good endometrial cancer service from an adequate one, and all of them are questions you can ask any centre and get a factual answer to. They are not about buildings, brochures or how many machines a hospital has. They are about how the nodes are assessed, whether the tumour is tested, who decides the plan after surgery, and whether anyone deals with what treatment leaves behind.
- Six askable questions — each with a factual answer, at any centre
- Not about equipment or size — a large hospital is not automatically a good service
- Node assessment method matters most — it determines your lymphoedema risk for life
- And who decides after surgery — a plan from one specialty reflects that specialty’s tools
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Criteria you can verify
The Six Questions Worth Asking Any Centre
Each of these has a factual answer that any centre can give you. Ask them of us, and ask them of anyone else you are considering.
How will my lymph nodes be assessed?
The single most consequential question, and it affects the rest of your life rather than only your treatment. Sentinel node mapping identifies the first nodes the uterus drains to and examines those in detail, providing the staging information that determines whether you need treatment after surgery while removing far fewer nodes than a systematic dissection — and therefore carrying a substantially lower risk of permanent leg lymphoedema, which is the main long-term complication of this surgery. Not every unit performs it routinely. Ask directly whether it is offered, and if the answer is that nodes will be removed systematically, ask why in your case. See sentinel node biopsy.
Will my tumour have full molecular classification?
Mismatch repair status, p53, and POLE where relevant. This is not an academic extra: it is built into the current FIGO staging system, it can move an adjuvant recommendation in either direction — a POLE-mutated tumour may warrant less treatment rather than more — it identifies women who may benefit from immunotherapy if disease recurs, and a minority of mismatch repair deficient results signal Lynch syndrome with implications for the whole family. All of it is performed on tissue already removed. A service that does not test every tumour is working with incomplete information. See MMR and MSI testing.
Who decides whether I need treatment after surgery?
The adjuvant decision weighs surgical, radiotherapy and systemic considerations together, and a recommendation assembled by one specialty in isolation tends to reflect that specialty's available interventions. Ask whether your case will be discussed at a genuine multidisciplinary tumour board with surgical, medical and radiation oncology present, along with pathology and radiology — and whether that happens before the recommendation reaches you rather than afterwards. This costs nothing extra and it changes plans. It matters most in exactly the finely balanced cases where the answer is not obvious. See the adjuvant decision.
Who will perform the surgery, and how often do they do it?
A fair question and not an impolite one — outcomes in complex surgery relate to how regularly a team performs a procedure, and any surgeon will answer it. Ask specifically whether minimally invasive surgery is offered, since randomised evidence shows equivalent cancer outcomes to open surgery with significantly less pain, fewer wound complications and a much shorter stay. Ask what the plan is if keyhole surgery proves unsafe during the operation. And ask whether the surgeon is a specialist in gynaecological cancer surgery rather than performing it occasionally alongside general work. See comparing the surgical routes.
Is radiotherapy, including vault brachytherapy, available on site?
This matters practically rather than clinically. Vaginal vault brachytherapy is a short course of a few outpatient sessions, and it stops being short when every session means travelling to a different hospital in another part of the city. The same applies more forcefully to pelvic radiation, which runs daily on weekdays for around five weeks. Fragmenting treatment across sites also fragments the planning — the surgeon and the radiation oncologist should be discussing your case, not corresponding about it. Ask where each element of your treatment would actually happen. See vault brachytherapy.
What happens after treatment finishes?
The question almost nobody asks and the one that shapes the following decade. Ask whether you will receive a written follow-up schedule naming who is responsible and when. Ask who manages menopause if your ovaries are removed, because it routinely falls between oncology and general practice with each assuming the other holds it. Ask whether lymphoedema therapy, pelvic floor physiotherapy, psycho-oncology and nutrition support are available and how they are accessed. A service that treats the cancer well and abandons you to its consequences has done half the job. See life after endometrial cancer treatment.
Did You Know? The most consequential difference between endometrial cancer services is not surgical skill in any dramatic sense — it is how the lymph nodes are assessed. Removing large numbers of pelvic nodes gives thorough staging at the cost of disrupting lymphatic drainage from the legs, and permanent leg swelling follows in a significant minority. Sentinel node mapping identifies and examines only the first nodes the uterus drains to, providing the same staging information that determines your treatment while leaving most of the lymphatic architecture intact. Not every unit offers it. It is one question, with a yes or no answer, and it affects the rest of your life. Sources: ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; FIGO staging system for cancer of the endometrium, 2023 revision.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What Matters Less Than You Might Expect
Several things that look like quality markers are weaker signals than the six questions above.
- Hospital size. A large general hospital is not automatically better at this than a focused cancer service, and may be worse if gynaecological cancer surgery is performed occasionally rather than regularly.
- Having the newest equipment. Robotic surgery is the same operation performed with different instruments, not a better operation. What matters is who is using it and how often. See laparoscopic versus robotic versus open.
- Published survival figures. Treat single-centre survival rates with caution, particularly for a cancer where Indian national comparison data is limited. Ask what population and period any quoted figure comes from.
- Proximity, up to a point. Genuinely relevant for five weeks of daily radiation, and much less so for a one-off operation. It is worth travelling further for the surgery and closer for the radiotherapy if those can be arranged.
- Cost alone. More expensive is not automatically better, and cheaper is not automatically worse — though a pathway that omits molecular testing or sentinel node mapping to save money is making a false economy. See treatment cost.
Want to Ask Us the Same Six Questions?
We will answer them factually, and if the plan you already have is right, we will tell you that too.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask the Same Six Questions Everywhere
The answers are factual, comparable, and considerably more informative than a brochure.
Four Answers That Should Give You Pause
None of these is proof of poor care. All of them warrant a follow-up question.
A complete treatment plan promised before surgery
Whether you need treatment after the operation is decided on the final pathology from the removed uterus, which takes two to three weeks. Grades and stages are revised in both directions at that point, and lymphovascular space invasion cannot be assessed beforehand at all. A team presenting a definitive complete plan at diagnosis is either simplifying for reassurance or has not explained the sequencing, and it is worth asking which.
Molecular testing described as optional or extra
It is built into the current FIGO staging system, it can reduce the treatment you need as well as increase it, and it identifies Lynch syndrome with implications for your relatives. A service that frames it as an optional add-on rather than standard practice is behind current guidance. If cost is the obstacle, that is a legitimate conversation to have — but it should be had explicitly rather than by omission.
Reluctance to answer how often the surgeon operates
A straightforward question with a factual answer, and any confident surgeon will give it. Deflection is informative. The same applies to asking whether the case will go to a tumour board, and to asking what happens if keyhole surgery proves unsafe during the operation — all are routine questions in cancer care and none should produce discomfort.
A quoted survival figure without a source
Particularly for endometrial cancer, where Indian national registry data is limited and single-centre figures are difficult to interpret. Ask what population it describes, over what period, and how the cases were selected. A service that quotes a headline number without being able to answer those questions is marketing rather than informing.
Want an Honest Comparison?
Bring your reports and ask us the six questions. If your current centre is doing the right things, we will say so. The opinion is free.
How to Actually Use This
A list of criteria is only useful if it can be applied under the conditions in which these decisions are really made — quickly, anxiously, and often with limited choice.
- Take the six questions to your existing appointment first. Most women do not need to change centres. Asking them where you already are frequently reveals that the service is good, or identifies one specific gap that can simply be filled — molecular testing being the commonest.
- Prioritise if you cannot have everything. If choice is limited, node assessment method and tumour board review are the two that most affect outcomes. Survivorship services can be accessed separately afterwards if necessary.
- Separate the surgery from the radiotherapy. They do not have to happen in the same place, and the considerations differ — expertise matters most for the operation, proximity matters most for five weeks of daily treatment.
- A second opinion is a legitimate way to compare. Bringing your reports to another centre lets you assess how they think, not only what they claim. See when a second opinion is worth it.
- And do not let the search delay treatment unduly. A few days or a week is fine for the common type. Months of shopping around is not, and the anxiety of indecision has its own cost.
How We Answer the Six Questions
Asked of us, these are the answers — and they are the same answers you should require of anyone.
Sentinel node mapping where it fits
MMR / MSI testing as standard
Tumour board for every diagnosis
Named MCh surgical oncologists
Vault brachytherapy on site
Survivorship care that is actually offered
Take The Next Step
Ask Where You Already Are, First
Most women do not need to change centres. The questions frequently confirm that, or identify one fixable gap.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Choosing a Centre — Frequently Asked Questions
What should I look for in an endometrial cancer centre?
Six things, each of which is a question with a factual answer that any centre can give you. How will my lymph nodes be assessed — sentinel mapping or systematic removal? Will my tumour have full molecular classification including mismatch repair, p53 and POLE? Who decides whether I need treatment after surgery, and is it a genuine multidisciplinary tumour board? Who will perform the surgery and how often do they do it, and is minimally invasive surgery offered? Is radiotherapy including vault brachytherapy available on site? And what happens after treatment finishes — is there a written follow-up plan and are survivorship services available?
Which of those matters most?
How the lymph nodes will be assessed, because it affects the rest of your life rather than only your treatment. Sentinel node mapping provides the same staging information that determines whether you need treatment after surgery, while removing far fewer nodes than a systematic dissection — and therefore carrying a substantially lower risk of permanent leg lymphoedema, which is the main long-term complication of this surgery and is difficult to treat once established. Not every unit offers it. After that, whether your case goes to a genuine multidisciplinary tumour board matters most, because the adjuvant decision weighs three specialties' considerations together.
Is a bigger hospital better?
Not automatically, and size is a weaker signal than most people assume. A large general hospital may perform gynaecological cancer surgery occasionally alongside a great deal of other work, while a focused cancer service may do it regularly. What matters is how often the specific team performs this specific operation, whether sentinel node mapping is available, whether molecular testing is routine, and whether a real multidisciplinary board reviews cases. Newest equipment is similarly a weak signal — robotic surgery is the same operation performed with different instruments, not a better operation, and what matters is who is using it.
Do I have to have all my treatment in one place?
No, and separating the components is sometimes the better arrangement. Surgical expertise matters most for the operation, which is a one-off event where it is worth travelling further. Proximity matters most for pelvic radiotherapy, which runs daily on weekdays for around five weeks and becomes considerably harder if it means crossing a city each day. The important caveat is that the teams should be communicating rather than working in parallel — ask how the surgeon and the radiation oncologist will discuss your case, and make sure your pathology and imaging travel with you.
How long should I spend choosing?
Days rather than months. For the common low-grade endometrioid cancer, a week spent taking your reports for a second opinion or asking the six questions at your existing centre is very unlikely to affect the outcome — this is a disease that has typically been developing over years by the time it causes bleeding. Where the diagnosis is serous carcinoma or carcinosarcoma, things should move faster. What is not worth doing is prolonged shopping around: the anxiety of indecision has its own cost, and most women find that asking the six questions where they already are answers the question.
Medical disclaimer: This page sets out criteria for assessing an endometrial cancer service and is reviewed by a CION oncologist, following current NCCN and ESGO–ESTRO–ESP guidance. The criteria described are questions any centre should be able to answer factually, and are intended to be applied wherever you are considering treatment. It is general information rather than advice about your own care, and choosing where to be treated should not be allowed to introduce substantial delay.